Quote:
Originally Posted by sketchowl
Key point - a NEW drug vs an in use druf for 4 plus decades. May not work great but does no harm (relative to other options).
And second point on adverse rate - mRNA studies of 40k participants. Ivermectin FDA studies then used in the wild with billions of doses administered so I feel plenty of data there to evaluate.
|
Also an old drug when it should be used in a new way.
Covid is a new thing.
Usage in real life isn’t the same as clinical studies.
If it’s not harmful that’s good, but the question still is, is it helpful.
And for that, you need big clinical studies.